Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia

NCT01190254 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01190254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01190254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
September 28, 2010
Completion date
April 1, 2013
Enrollment
306 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, disorganized, schizophrenia, paranoid, schizophrenia, undifferentiated